Keyword: Valeant Pharmaceuticals
US WorldMeds needed a partner to help launch its first-ever opioid withdrawal med Lucemyra, and Valeant’s Salix has taken the job.
Wells Fargo analyst depicted the rejection as “a major setback” for Valeant that puts a dent in the company’s five-year growth plan.
Now that former shareholders of Sprout have the company back in their hands, they’ve reinstalled a familiar face at the helm.
A jury today found a former exec of mail order pharmacy Philidor and a former Valeant Pharmaceuticals exec guilty of defrauding the drugmaker.
A former Valeant executive suspected an illicit relationship between a colleague and mail order pharmacy Philidor, he testified.
Valeant is getting a new name and stock ticker to press ahead after its storied downfall.
With news of a refinancing and management change, Concordia shares plunged deeper into penny-stock territory.
The murky relationship between Valeant and now-defunct specialty pharmacy Philidor will spotlight a not-so-flattering chapter in its recent history.
Valeant CEO Joseph Papa’s 2017 paycheck looked a quite different from his 2016 version. About $57 million different, in fact.
California is starting to see early results from its new drug price transparency law, with red flags raised on two big hikes.